CAML Rheumatology Series 2025/26 – Talk in January

/in /by

🗓️ Save the Date!

📣 The CAML Rheumatology Series 2025/26 continues with a not-to-be-missed session on the 20th of January 2026 at 9 am (WET).

🎤 Prof. Xenofon Baraliakos from the Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, will speak on:
👉 “Unmet Needs in Spondyloarthritis: Status 2026”

📍 Attend in person:
Auditório 57, Edifício Egas Moniz, School of Medicine, University of Lisbon

💻 Or join online: https://lnkd.in/dBdYS2be

Let’s continue the dialogue on innovation, gaps, and next steps in managing spondyloarthritis across Europe.

Project Coordinator Team

Helsinki University Hospital (HUS)
Helsinki, Finland

ENDOTARGET Project Coordinator

Kari Eklund
kari.eklund@hus.fi

ENDOTARGET Deputy Project Coordinator

Gonçalo Barreto
goncalo.barreto@helsinki.fi

ENDOTARGET Project Manager

Ana Valkama
ana.valkama@hus.fi

Communication & Dissemination Leader

Steinbeis Europa Zentrum (SEZ)
Stuttgart, Germany

Lena Schleicher
lena.schleicher@steinbeis-europa.de

Disclaimer

©2023-2026 ENDOTARGET Consortium Partners. All rights reserved.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. The European Union cannot be held responsible for them.

ENDOTARGET is a Horizon Europe project supported by the European Commission under grant agreement No 101095084. All information in this deliverable may not be copied or duplicated in whole or part by any means without express prior agreement in writing by the ENDOTARGET partners. All contents are reserved by default and may not be disclosed to third parties without the written consent of the ENDOTARGET partners, except as mandated by the Grant Agreement with the European Commission, for reviewing and dissemination purposes. All trademarks and other rights on third party products mentioned in this document are acknowledged and owned by the respective holders. The ENDOTARGET consortium does not guarantee that any information contained herein is error-free, or up-to-date, nor makes warranties, express, implied, or statutory, by publishing this document.

First WP6 Meeting in 2026Glycantrigger meets ENDOTARGET